We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Specifications: Spike glycoprotein from SARS-CoV-2: NCBI the RefSeq (YP_009724390.1) of 1273 aa Peptide length: 15 aa, 9aa for the C-terminal peptide. Gross peptide weight: not quantified Synthesis scale: 5 µmol Offset number: 7 aa Format: lyophilized in 96-well plate (P-DW-20-C Axygen®) Counter ion: TFA QC validation: MALDI-TOF QC on 10 % of peptidesCoronavirus Spike glycoproteins mediate the virus attachment to host cell surface receptors and facilitate the virus entry by assisting fusion between viral and host cell membranes. They are composed of two subunits, S1 and S2. The Spike protein of SARS-CoV-2 harbors furin cleavage sites, one being located at the boundary between S1 and S2.Spike glycoproteins are extensively studied as targets for antibodies, vaccine candidates or protease inhibitors, as examples.We developed a peptide library spanning the entire Spike glycoprotein from SARS-CoV-2. The library is provided in a convenient 96-well plate format adapted for screening purposes.
Peptide Library Construction and Screening
Powerful screening tools in biological and chemical research
Purity | Crude |
Size | 5 µmol |
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
Required fields are marked with *
×Required fields are marked with *
×If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com